ABBVIE INC. vs. IDEAYA Biosciences, Inc. Common Stock
ABBVIE INC. (ABBV) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ABBV | IDYA | |
|---|---|---|
| Market Cap | $457.54 billion | $3.66 billion |
| Revenue (TTM) | $64.39 billion | $234.13 million |
| Net Income (TTM) | $6.32 billion | $-175,020,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | IDYA | |
|---|---|---|
| P/E Ratio | 75.13 | — |
| Price / Book | -77.71 | 3.05 |
| Price / Sales | 7.11 | 15.63 |
ABBV leads on 2 of 2 valuation factors.
Profitability
| ABBV | IDYA | |
|---|---|---|
| Net Margin | 9.81% | -74.75% |
| Return on Equity | -107.29% | -14.60% |
ABBV and IDYA split the profitability factors evenly.
Dividend
| ABBV | IDYA | |
|---|---|---|
| Dividend Yield | 2.60% | — |
| Payout Ratio | 195.48 | — |
ABBV and IDYA split the dividend factors evenly.
Risk & Sentiment
| ABBV | IDYA | |
|---|---|---|
| Short Interest | 0.85% | 0.14% |
IDYA leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, IDYA overview, IDYA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.